Member Info for SneakySimon

The contract is a minimum £50m

No-one is expecting the financial year to give us much as per the Feb RNS

Where we will all be interested is the future outlook and the answers to the investor questions - this is the unknown as to what Col will be able to tell us and the manner - I think from memory most presentations hurt the SP - so I am praying this is better and coupled with some real, tangible infomation.

My parents are high risk and been shielding most of the pandemic - they have had 2 shots, but don't want to go out in case they don't have antibodies - really want this antibody test to be available for them to be able to feel comfortable going out.

Kieran Harbinson

"Head responsibility for all financial, accounting, tax and investor relations activities for an AIM listed Company"

Doing well on the investor relations 12th Feb - largest director sales of £157k (regular sell) and £820k (options sell)

This is exactly the issue - until real tangible facts are laid out, it is all promises and hopes.

I am optomisitic that next week will bring some news, bit also fully aware of the quality of presentations and Colin's ability to repeatedly use vague / negative wording which generally creates an SP drop - if he has nothing more substansive than a 'we are talking to DHSC / the capacity has been increased / we are pouching / hoping for FDA EUA and European approval' then he needn't bother.

Exact Bojo response:

"I don't think that is entirely true categorisation of what the govt is doing, on the contra we have worked night and day to build up our domestic lateral flow capacity"

So, acknowledging the domestic LFT capacity increase, though we knew that already!

Great find Crispy - do you have the ref numbers, the link doesn’t work for me

Thought you were in already Chris?

Promotional Twitter I get the impression was Walbrook getting a bit ahead of themselves........

Disagree

LFT wise, they have 2m capacity
1m govt (on loaned machine)
1m split 200k pw ABC-19 and 800k Visitect

I assume also they have been using the govt machine - this maybe producing ABC-19 (since that is a govt test and Abingdon seem to be on the naughty step) or Visitect test - I doubt it has been gathering dust!

Oh dear god - Walter Mitty is still playing this 'colin is my mate' story - geez, you can tell their is crap comms when this is happening!!

Sounding positive - the SP is abysmal as usual - thanks Colin and Walbrook for some truly awful PR and comms - clearly only bother when the directors want to sell.

Continues. Work through these then another load gets spewed. No chart comparisons this year I imagine.

Saudi news sound like it’ll be signing licences and little more. Happy to be corrected. Presumably no time scale for ratification? I wonder when that DRC contract was signed. I suspect before PF’s lastest badge was awarded. Waiting for ratification might have commenced many month ago.

Face value!! :) You’d be mad too. History and the SP suggests ongoing scepticism.

Just need to wait for news - we hope it should be soon.

AVCT changing from the previous 'we will sell everything we make' to 'we will increase manufacturing if demand increases' was a real dampner but hopefully we will rise above that.

ii's won't buy into ODX - it is too bouncy (generally down at the moment) due to poor comms - the rampy stuff on twitter, the very poor RNS's even on positive news and the then absurd long periods of silence. Then add directors selling on mass a few months ago, if you don't scratch the surface, you could be forgiven for thinking this company is a fraud!

Colin has mentioned a couple of times that the year end results are what he cares about, day to day movement on the SP is not - hence why I believe the SP bounces around and dies - and it has nothing to do with MM's - it is down to the company providing very little comms or updates.

Interesting - I hope with govt connections we will move onto other tests post the covid demand (which I see only reducing but not ending)

I am anticipating sepsis testing and / or a test that can distinguish between flu and covid - that would be incredibly useful longer term.

Guy changes his tune (and deletes his tweets' all the time

Can't take him seriously.

All investing is an element of chance - at a high level, ODX looks a good bet in the AIM soup:
- government contrcat of up to £374m for 1m per week (ie half our production capacity of LFT)
- also producing the ABC-19 test which we have seen is specifically mentioned in the code for the NHS APP
- the Visitect antigen LFT (Mologic) which as per Mologic updates has passed in Germany and looking for home use and in USA has received millions in funding and has had several independent reviews (as we see with Innova, company clinical studies are not worth much and always tend to be very high S&S)
- the company continues to recruit
- we have been paid the first part of the govt money
- we are actively working with the govt - packaging and choosing a test to manufacture - I know not a great shake but its money coming in and shows a relationship

Therefore, I take on board the risks and think ODX has a good opportunity to do well. The SP is largely the uncertainty that is from the lack of updates and the generally downcast updates even on positive news - frustrating but it will eventually come to fruition.

I am sure I have heard Colin mention this a couple of times, but he see's the CEO role to deliver turnover and profit and report this at the end of the year - with this being his focus, then makes it a bit clearer why the SP movement isn't really much of a concern.

I don't love that approach - something more upbeat would be better but that's my selfish view as a shareholder (and why it irked me the rampy tweeting that went on around the director sells!)

Will

If you can name me one of the following, I will bow down to your knowledge
1. Which Spanish hospital was the testing done at?
2. Who authored the Clinical Study

I still wonder why it has not been shared and peer reviewed?